These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18762354)

  • 1. Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer's disease.
    Cheng H; Zhou Y; Holtzman DM; Han X
    Neurobiol Aging; 2010 Jul; 31(7):1188-96. PubMed ID: 18762354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.
    Bales KR; Verina T; Cummins DJ; Du Y; Dodel RC; Saura J; Fishman CE; DeLong CA; Piccardo P; Petegnief V; Ghetti B; Paul SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15233-8. PubMed ID: 10611368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment.
    Qiu S; Palavicini JP; Wang J; Gonzalez NS; He S; Dustin E; Zou C; Ding L; Bhattacharjee A; Van Skike CE; Galvan V; Dupree JL; Han X
    Mol Neurodegener; 2021 Sep; 16(1):64. PubMed ID: 34526055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E alters the processing of the beta-amyloid precursor protein in APP(V717F) transgenic mice.
    Dodart JC; Bales KR; Johnstone EM; Little SP; Paul SM
    Brain Res; 2002 Nov; 955(1-2):191-9. PubMed ID: 12419536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenic implication of abnormal interaction between apolipoprotein E isoforms, amyloid-beta peptides, and sulfatides in Alzheimer's disease.
    Han X
    Mol Neurobiol; 2010 Jun; 41(2-3):97-106. PubMed ID: 20052565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer's disease: a tale of shotgun lipidomics.
    Han X
    J Neurochem; 2007 Nov; 103 Suppl 1(Suppl 1):171-9. PubMed ID: 17986152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel role for apolipoprotein E in the central nervous system. Modulation of sulfatide content.
    Han X; Cheng H; Fryer JD; Fagan AM; Holtzman DM
    J Biol Chem; 2003 Mar; 278(10):8043-51. PubMed ID: 12501252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bidirectional link between sulfatide and Alzheimer's disease.
    Zimmer VC; Lauer AA; Haupenthal V; Stahlmann CP; Mett J; Grösgen S; Hundsdörfer B; Rothhaar T; Endres K; Eckhardt M; Hartmann T; Grimm HS; Grimm MOW
    Cell Chem Biol; 2024 Feb; 31(2):265-283.e7. PubMed ID: 37972592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.
    Sawmiller D; Habib A; Hou H; Mori T; Fan A; Tian J; Zeng J; Giunta B; Sanberg PR; Mattson MP; Tan J
    Biol Psychiatry; 2019 Aug; 86(3):208-220. PubMed ID: 31208706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profile of the PDAPP mouse model for Alzheimer's disease with and without Apolipoprotein E.
    Selwood SP; Parvathy S; Cordell B; Ryan HS; Oshidari F; Vincent V; Yesavage J; Lazzeroni LC; Murphy GM
    Neurobiol Aging; 2009 Apr; 30(4):574-90. PubMed ID: 17904698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.
    Holtzman DM; Bales KR; Tenkova T; Fagan AM; Parsadanian M; Sartorius LJ; Mackey B; Olney J; McKeel D; Wozniak D; Paul SM
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2892-7. PubMed ID: 10694577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice.
    Fryer JD; Taylor JW; DeMattos RB; Bales KR; Paul SM; Parsadanian M; Holtzman DM
    J Neurosci; 2003 Aug; 23(21):7889-96. PubMed ID: 12944519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.
    Fitz NF; Tapias V; Cronican AA; Castranio EL; Saleem M; Carter AY; Lefterova M; Lefterov I; Koldamova R
    Brain; 2015 Dec; 138(Pt 12):3699-715. PubMed ID: 26510953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice.
    Pankiewicz JE; Guridi M; Kim J; Asuni AA; Sanchez S; Sullivan PM; Holtzman DM; Sadowski MJ
    Acta Neuropathol Commun; 2014 Jun; 2():75. PubMed ID: 24972680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice.
    Irizarry MC; Cheung BS; Rebeck GW; Paul SM; Bales KR; Hyman BT
    Acta Neuropathol; 2000 Nov; 100(5):451-8. PubMed ID: 11045665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain.
    Carter DB; Dunn E; McKinley DD; Stratman NC; Boyle TP; Kuiper SL; Oostveen JA; Weaver RJ; Boller JA; Gurney ME
    Ann Neurol; 2001 Oct; 50(4):468-75. PubMed ID: 11601499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease.
    Rolyan H; Feike AC; Upadhaya AR; Waha A; Van Dooren T; Haass C; Birkenmeier G; Pietrzik CU; Van Leuven F; Thal DR
    J Neural Transm (Vienna); 2011 May; 118(5):699-712. PubMed ID: 21210284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer's disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling.
    Zheng JY; Sun J; Ji CM; Shen L; Chen ZJ; Xie P; Sun YZ; Yu RT
    Neurobiol Aging; 2017 Jun; 54():112-132. PubMed ID: 28366226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
    Poirier J
    Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer's disease mice.
    Kaya I; Jennische E; Lange S; Tarik Baykal A; Malmberg P; Fletcher JS
    J Neurochem; 2020 Jul; 154(1):84-98. PubMed ID: 32141089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.